Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Observation × 1 year × Clear all

Sponsor

Conditions

Neoplasms 9 Prostatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Endometrial Neoplasms 7 Lung Neoplasms 6 Breast Neoplasms 6 Colorectal Neoplasms 5 Oropharyngeal Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Mouth Neoplasms 3 Leukemia, Myeloid, Acute 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Skin Neoplasms 2 Sarcoma 2 Pathologic Complete Response 2 Meningioma 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Leiomyoma 2 Esophageal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Brain Neoplasms 2 Bone Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡